Skip to main content
Erschienen in: Cancer Causes & Control 5/2019

22.03.2019 | Original Paper

Flavonoids and bladder cancer risk

verfasst von: Marta Rossi, Panagiota Strikoudi, Maria-Eleni Spei, Maria Parpinel, Diego Serraino, Maurizio Montella, Massimo Libra, Carlo La Vecchia, Valentina Rosato

Erschienen in: Cancer Causes & Control | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Flavonoids have drawn attention because of their antioxidant capacity and anti-carcinogenic effect in various types of cancer. A limited number of studies has investigated their potential effect on the risk of bladder cancer, with inconsistent results.

Methods

We analyzed data from an Italian case–control study including 690 incident bladder cancer cases and 665 controls admitted to the same network of hospitals for acute, non-neoplastic, non tobacco-related diseases. Subjects were interviewed using a reproducible and validated food-frequency questionnaire. We applied data on food and beverage composition to estimate the intake of isoflavones, anthocyanidins, flavan-3-ols, flavanones, flavones and flavonols. We estimated odds ratios (ORs) through multiple logistic regression models, including terms for potential confounding factors, including tobacco smoking and total energy intake.

Results

We found an inverse association between isoflavones (OR for the highest compared to the lowest quintile of intake = 0.56, 95% CI 0.37–0.84) and flavones (OR = 0.64, 95% CI 0.44–0.95) and bladder cancer. Non-significant inverse association was found for flavan-3-ols (OR = 0.70), flavonols (OR = 0.85) and total flavonoids (OR = 0.76). The results were consistent for non-muscle-invasive and muscle-invasive bladder cancers.

Conclusions

Our data indicate an inverse association between isoflavones and flavones with respect to bladder cancer risk.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234–241CrossRefPubMed Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234–241CrossRefPubMed
2.
Zurück zum Zitat Turati F, Polesel J, Di Maso M, Montella M, Libra M, Grimaldi M, Tavani A, Serraino D, La Vecchia C, Bosetti C (2015) Diabetes mellitus and the risk of bladder cancer: an Italian case–control study. Br J Cancer 113:127–130CrossRefPubMedPubMedCentral Turati F, Polesel J, Di Maso M, Montella M, Libra M, Grimaldi M, Tavani A, Serraino D, La Vecchia C, Bosetti C (2015) Diabetes mellitus and the risk of bladder cancer: an Italian case–control study. Br J Cancer 113:127–130CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Bedwani R, Renganathan E, El Kwhsky F, Braga C, Abu Seif HH, Abul Azm T, Zaki A, Franceschi S, Boffetta P, La Vecchia C (1998) Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer 77:1186–1189CrossRefPubMedPubMedCentral Bedwani R, Renganathan E, El Kwhsky F, Braga C, Abu Seif HH, Abul Azm T, Zaki A, Franceschi S, Boffetta P, La Vecchia C (1998) Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer 77:1186–1189CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat La Vecchia C, Negri E, D’Avanzo B, Savoldelli R, Franceschi S (1991) Genital and urinary tract diseases and bladder cancer. Cancer Res 51:629–631PubMed La Vecchia C, Negri E, D’Avanzo B, Savoldelli R, Franceschi S (1991) Genital and urinary tract diseases and bladder cancer. Cancer Res 51:629–631PubMed
5.
Zurück zum Zitat Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C (2006) Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol 3:327–340CrossRefPubMed Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C (2006) Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol 3:327–340CrossRefPubMed
6.
Zurück zum Zitat D’Avanzo B, La Vecchia C, Negri E, Decarli A, Benichou J (1995) Attributable risks for bladder cancer in northern Italy. Ann Epidemiol 5:427–431CrossRefPubMed D’Avanzo B, La Vecchia C, Negri E, Decarli A, Benichou J (1995) Attributable risks for bladder cancer in northern Italy. Ann Epidemiol 5:427–431CrossRefPubMed
7.
Zurück zum Zitat Turati F, Bosetti C, Polesel J, Serraino D, Montella M, Libra M, Facchini G, Ferraroni M, Tavani A, La Vecchia C, Negri E (2017) Family history of cancer and the risk of bladder cancer: A case–control study from Italy. Cancer Epidemiol 48:29–35CrossRefPubMed Turati F, Bosetti C, Polesel J, Serraino D, Montella M, Libra M, Facchini G, Ferraroni M, Tavani A, La Vecchia C, Negri E (2017) Family history of cancer and the risk of bladder cancer: A case–control study from Italy. Cancer Epidemiol 48:29–35CrossRefPubMed
8.
Zurück zum Zitat Smith AH, Marshall G, Roh T, Ferreccio C, Liaw J, Steinmaus C (2018) Lung, bladder, and kidney cancer mortality 40 years after arsenic exposure reduction. J Natl Cancer Inst 110:241–249CrossRefPubMed Smith AH, Marshall G, Roh T, Ferreccio C, Liaw J, Steinmaus C (2018) Lung, bladder, and kidney cancer mortality 40 years after arsenic exposure reduction. J Natl Cancer Inst 110:241–249CrossRefPubMed
9.
Zurück zum Zitat World Cancer Research Fund International/American Institute for Cancer Research (2015) Continuous update project report: diet, nutrition, physical activity and bladder cancer World Cancer Research Fund International/American Institute for Cancer Research (2015) Continuous update project report: diet, nutrition, physical activity and bladder cancer
10.
Zurück zum Zitat Liu H, Wang XC, Hu GH, Guo ZF, Lai P, Xu L, Huang TB, Xu YF (2015) Fruit and vegetable consumption and risk of bladder cancer: an updated meta-analysis of observational studies. Eur J Cancer Prev 24:508–516CrossRefPubMed Liu H, Wang XC, Hu GH, Guo ZF, Lai P, Xu L, Huang TB, Xu YF (2015) Fruit and vegetable consumption and risk of bladder cancer: an updated meta-analysis of observational studies. Eur J Cancer Prev 24:508–516CrossRefPubMed
11.
Zurück zum Zitat Yao B, Yan Y, Ye X, Fang H, Xu H, Liu Y, Li S, Zhao Y (2014) Intake of fruit and vegetables and risk of bladder cancer: a dose-response meta-analysis of observational studies. Cancer Causes Control 25:1645–1658CrossRefPubMed Yao B, Yan Y, Ye X, Fang H, Xu H, Liu Y, Li S, Zhao Y (2014) Intake of fruit and vegetables and risk of bladder cancer: a dose-response meta-analysis of observational studies. Cancer Causes Control 25:1645–1658CrossRefPubMed
12.
13.
Zurück zum Zitat Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. review of 97 bioavailability studies. Am J Clin Nutr 81:230S–242SCrossRefPubMed Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. review of 97 bioavailability studies. Am J Clin Nutr 81:230S–242SCrossRefPubMed
14.
Zurück zum Zitat Rossi M, Negri E, Talamini R, Bosetti C, Parpinel M, Gnagnarella P, Franceschi S, Dal Maso L, Montella M, Giacosa A, La Vecchia C (2006) Flavonoids and colorectal cancer in Italy. Cancer Epidemiol Biomarkers Prev 15:1555–1558CrossRefPubMed Rossi M, Negri E, Talamini R, Bosetti C, Parpinel M, Gnagnarella P, Franceschi S, Dal Maso L, Montella M, Giacosa A, La Vecchia C (2006) Flavonoids and colorectal cancer in Italy. Cancer Epidemiol Biomarkers Prev 15:1555–1558CrossRefPubMed
15.
Zurück zum Zitat Rossi M, Bosetti C, Negri E, Lagiou P, La Vecchia C (2010) Flavonoids, proanthocyanidins, and cancer risk: a network of case–control studies from Italy. Nutr Cancer 62:871–877CrossRefPubMed Rossi M, Bosetti C, Negri E, Lagiou P, La Vecchia C (2010) Flavonoids, proanthocyanidins, and cancer risk: a network of case–control studies from Italy. Nutr Cancer 62:871–877CrossRefPubMed
16.
Zurück zum Zitat Rossi M, Rosato V, Bosetti C, Lagiou P, Parpinel M, Bertuccio P, Negri E, La Vecchia C (2010) Flavonoids, proanthocyanidins, and the risk of stomach cancer. Cancer Causes Control 21:1597–1604CrossRefPubMed Rossi M, Rosato V, Bosetti C, Lagiou P, Parpinel M, Bertuccio P, Negri E, La Vecchia C (2010) Flavonoids, proanthocyanidins, and the risk of stomach cancer. Cancer Causes Control 21:1597–1604CrossRefPubMed
18.
Zurück zum Zitat USDA database for the (2003) Flavonoid content of selected foods. USDA, Beltsville USDA database for the (2003) Flavonoid content of selected foods. USDA, Beltsville
19.
Zurück zum Zitat Singh AV, Franke AA, Blackburn GL, Zhou JR (2006) Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Res 66:1851–1858CrossRefPubMedPubMedCentral Singh AV, Franke AA, Blackburn GL, Zhou JR (2006) Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Res 66:1851–1858CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Zamora-Ros R, Sacerdote C, Ricceri F, Weiderpass E, Roswall N, Buckland G, St-Jules DE, Overvad K, Kyro C, Fagherazzi G, Kvaskoff M, Severi G, Chang-Claude J, Kaaks R, Nothlings U, Trichopoulou A, Naska A, Trichopoulos D, Palli D, Grioni S, Mattiello A, Tumino R, Gram IT, Engeset D, Huerta JM, Molina-Montes E, Arguelles M, Amiano P, Ardanaz E, Ericson U, Lindkvist B, Nilsson LM, Kiemeney LA, Ros M, Bueno-de-Mesquita HB, Peeters PH, Khaw KT, Wareham NJ, Knaze V, Romieu I, Scalbert A, Brennan P, Wark P, Vineis P, Riboli E, Gonzalez CA (2014) Flavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Cancer 111:1870–1880CrossRefPubMedPubMedCentral Zamora-Ros R, Sacerdote C, Ricceri F, Weiderpass E, Roswall N, Buckland G, St-Jules DE, Overvad K, Kyro C, Fagherazzi G, Kvaskoff M, Severi G, Chang-Claude J, Kaaks R, Nothlings U, Trichopoulou A, Naska A, Trichopoulos D, Palli D, Grioni S, Mattiello A, Tumino R, Gram IT, Engeset D, Huerta JM, Molina-Montes E, Arguelles M, Amiano P, Ardanaz E, Ericson U, Lindkvist B, Nilsson LM, Kiemeney LA, Ros M, Bueno-de-Mesquita HB, Peeters PH, Khaw KT, Wareham NJ, Knaze V, Romieu I, Scalbert A, Brennan P, Wark P, Vineis P, Riboli E, Gonzalez CA (2014) Flavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Cancer 111:1870–1880CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Garcia R, Gonzalez CA, Agudo A, Riboli E (1999) High intake of specific carotenoids and flavonoids does not reduce the risk of bladder cancer. Nutr Cancer 35:212–214CrossRefPubMed Garcia R, Gonzalez CA, Agudo A, Riboli E (1999) High intake of specific carotenoids and flavonoids does not reduce the risk of bladder cancer. Nutr Cancer 35:212–214CrossRefPubMed
22.
Zurück zum Zitat Sun CL, Yuan JM, Arakawa K, Low SH, Lee HP, Yu MC (2002) Dietary soy and increased risk of bladder cancer: the Singapore Chinese health study. Cancer Epidemiol Biomarkers Prev 11:1674–1677PubMed Sun CL, Yuan JM, Arakawa K, Low SH, Lee HP, Yu MC (2002) Dietary soy and increased risk of bladder cancer: the Singapore Chinese health study. Cancer Epidemiol Biomarkers Prev 11:1674–1677PubMed
23.
Zurück zum Zitat Arts IC, Jacobs DR Jr, Gross M, Harnack LJ, Folsom AR (2002) Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women’s health study (United States). Cancer Causes Control 13:373–382CrossRefPubMed Arts IC, Jacobs DR Jr, Gross M, Harnack LJ, Folsom AR (2002) Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women’s health study (United States). Cancer Causes Control 13:373–382CrossRefPubMed
24.
Zurück zum Zitat Sun CL, Yuan JM, Wang XL, Gao YT, Ross RK, Yu MC (2004) Dietary soy and increased risk of bladder cancer: a prospective cohort study of men in Shanghai, China. Int J Cancer 112:319–323CrossRefPubMed Sun CL, Yuan JM, Wang XL, Gao YT, Ross RK, Yu MC (2004) Dietary soy and increased risk of bladder cancer: a prospective cohort study of men in Shanghai, China. Int J Cancer 112:319–323CrossRefPubMed
25.
Zurück zum Zitat Turati F, Bosetti C, Polesel J, Zucchetto A, Serraino D, Montella M, Libra M, Galfano A, La Vecchia C, Tavani A (2015) Coffee, tea, cola, and bladder cancer risk: dose and time relationships. Urology 86:1179–1184CrossRefPubMed Turati F, Bosetti C, Polesel J, Zucchetto A, Serraino D, Montella M, Libra M, Galfano A, La Vecchia C, Tavani A (2015) Coffee, tea, cola, and bladder cancer risk: dose and time relationships. Urology 86:1179–1184CrossRefPubMed
26.
Zurück zum Zitat Shivappa N, Hebert JR, Rosato V, Rossi M, Libra M, Montella M, Serraino D, La Vecchia C (2017) Dietary inflammatory index and risk of bladder cancer in a large Italian case–control study. Urology 100:84–89CrossRefPubMed Shivappa N, Hebert JR, Rosato V, Rossi M, Libra M, Montella M, Serraino D, La Vecchia C (2017) Dietary inflammatory index and risk of bladder cancer in a large Italian case–control study. Urology 100:84–89CrossRefPubMed
27.
Zurück zum Zitat Decarli A, Franceschi S, Ferraroni M, Gnagnarella P, Parpinel MT, La Vecchia C, Negri E, Salvini S, Falcini F, Giacosa A (1996) Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for specific nutrients. Ann Epidemiol 6:110–118CrossRefPubMed Decarli A, Franceschi S, Ferraroni M, Gnagnarella P, Parpinel MT, La Vecchia C, Negri E, Salvini S, Falcini F, Giacosa A (1996) Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for specific nutrients. Ann Epidemiol 6:110–118CrossRefPubMed
28.
Zurück zum Zitat Franceschi S, Negri E, Salvini S, Decarli A, Ferraroni M, Filiberti R, Giacosa A, Talamini R, Nanni O, Panarello G et al (1993) Reproducibility of an Italian food frequency questionnaire for cancer studies: results for specific food items. Eur J Cancer 29A:2298–2305CrossRefPubMed Franceschi S, Negri E, Salvini S, Decarli A, Ferraroni M, Filiberti R, Giacosa A, Talamini R, Nanni O, Panarello G et al (1993) Reproducibility of an Italian food frequency questionnaire for cancer studies: results for specific food items. Eur J Cancer 29A:2298–2305CrossRefPubMed
29.
Zurück zum Zitat Iowa State University database on the isoflavone content of foods, Release 1.3. Beltsville, MD: USDA (2002) Iowa State University database on the isoflavone content of foods, Release 1.3. Beltsville, MD: USDA (2002)
30.
Zurück zum Zitat Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA (2000) Daidzein and genistein content of fruits and nuts. J Nutr Biochem 11:326–331CrossRefPubMed Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA (2000) Daidzein and genistein content of fruits and nuts. J Nutr Biochem 11:326–331CrossRefPubMed
31.
Zurück zum Zitat Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA (2000) Daidzein and genistein contents of vegetables. Br J Nutr 84:717–725CrossRef Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA (2000) Daidzein and genistein contents of vegetables. Br J Nutr 84:717–725CrossRef
32.
Zurück zum Zitat Liggins J, Mulligan A, Runswick S, Bingham SA (2002) Daidzein and genistein content of cereals. Eur J Clin Nutr 56:961–966CrossRefPubMed Liggins J, Mulligan A, Runswick S, Bingham SA (2002) Daidzein and genistein content of cereals. Eur J Clin Nutr 56:961–966CrossRefPubMed
33.
Zurück zum Zitat Gnagnarella P, Parpinel M, Salvini S, Franceschi S, Palli D, Boyle P (2004) The update of the Italian food composition database. J Food Comp Anal 17:509–522CrossRef Gnagnarella P, Parpinel M, Salvini S, Franceschi S, Palli D, Boyle P (2004) The update of the Italian food composition database. J Food Comp Anal 17:509–522CrossRef
34.
Zurück zum Zitat Willett W, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124:17–27CrossRefPubMed Willett W, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124:17–27CrossRefPubMed
35.
Zurück zum Zitat Aune D, De Stefani E, Ronco A, Boffetta P, Deneo-Pellegrini H, Acosta G, Mendilaharsu M (2009) Legume intake and the risk of cancer: a multisite case–control study in Uruguay. Cancer Causes Control 20:1605–1615CrossRefPubMed Aune D, De Stefani E, Ronco A, Boffetta P, Deneo-Pellegrini H, Acosta G, Mendilaharsu M (2009) Legume intake and the risk of cancer: a multisite case–control study in Uruguay. Cancer Causes Control 20:1605–1615CrossRefPubMed
36.
Zurück zum Zitat Schabath MB, Spitz MR, Lerner SP, Pillow PC, Hernandez LM, Delclos GL, Grossman HB, Wu X (2005) Case–control analysis of dietary folate and risk of bladder cancer. Nutr Cancer 53:144–151CrossRefPubMed Schabath MB, Spitz MR, Lerner SP, Pillow PC, Hernandez LM, Delclos GL, Grossman HB, Wu X (2005) Case–control analysis of dietary folate and risk of bladder cancer. Nutr Cancer 53:144–151CrossRefPubMed
37.
Zurück zum Zitat Park OJ, Surh YJ (2004) Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol Lett 150:43–56CrossRefPubMed Park OJ, Surh YJ (2004) Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol Lett 150:43–56CrossRefPubMed
38.
Zurück zum Zitat Su SJ, Yeh TM, Lei HY, Chow NH (2000) The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin Cancer Res 6:230–236PubMed Su SJ, Yeh TM, Lei HY, Chow NH (2000) The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin Cancer Res 6:230–236PubMed
39.
Zurück zum Zitat Wang Y, Wang H, Zhang W, Shao C, Xu P, Shi CH, Shi JG, Li YM, Fu Q, Xue W, Lei YH, Gao JY, Wang JY, Gao XP, Li JQ, Yuan JL, Zhang YT (2013) Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM/NF-kappaB/IKK pathway-induced apoptosis. PLoS ONE 8:e50175CrossRefPubMedPubMedCentral Wang Y, Wang H, Zhang W, Shao C, Xu P, Shi CH, Shi JG, Li YM, Fu Q, Xue W, Lei YH, Gao JY, Wang JY, Gao XP, Li JQ, Yuan JL, Zhang YT (2013) Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM/NF-kappaB/IKK pathway-induced apoptosis. PLoS ONE 8:e50175CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Theodorescu D, Laderoute KR, Calaoagan JM, Guilding KM (1998) Inhibition of human bladder cancer cell motility by genistein is dependent on epidermal growth factor receptor but not p21ras gene expression. Int J Cancer 78:775–782CrossRefPubMed Theodorescu D, Laderoute KR, Calaoagan JM, Guilding KM (1998) Inhibition of human bladder cancer cell motility by genistein is dependent on epidermal growth factor receptor but not p21ras gene expression. Int J Cancer 78:775–782CrossRefPubMed
41.
Zurück zum Zitat Su S, Lai M, Yeh T, Chow N (2001) Overexpression of HER-2/neu enhances the sensitivity of human bladder cancer cells to urinary isoflavones. Eur J Cancer 37:1413–1418CrossRefPubMed Su S, Lai M, Yeh T, Chow N (2001) Overexpression of HER-2/neu enhances the sensitivity of human bladder cancer cells to urinary isoflavones. Eur J Cancer 37:1413–1418CrossRefPubMed
42.
Zurück zum Zitat Su SJ, Yeh TM, Chuang WJ, Ho CL, Chang KL, Cheng HL, Liu HS, Cheng HL, Hsu PY, Chow NH (2005) The novel targets for anti-angiogenesis of genistein on human cancer cells. Biochem Pharmacol 69:307–318CrossRefPubMed Su SJ, Yeh TM, Chuang WJ, Ho CL, Chang KL, Cheng HL, Liu HS, Cheng HL, Hsu PY, Chow NH (2005) The novel targets for anti-angiogenesis of genistein on human cancer cells. Biochem Pharmacol 69:307–318CrossRefPubMed
43.
Zurück zum Zitat Russo M, Russo GL, Daglia M, Kasi PD, Ravi S, Nabavi SF, Nabavi SM (2016) Understanding genistein in cancer: the “good” and the “bad” effects: a review. Food Chem 196:589–600CrossRefPubMed Russo M, Russo GL, Daglia M, Kasi PD, Ravi S, Nabavi SF, Nabavi SM (2016) Understanding genistein in cancer: the “good” and the “bad” effects: a review. Food Chem 196:589–600CrossRefPubMed
44.
Zurück zum Zitat Kilani-Jaziri S, Frachet V, Bhouri W, Ghedira K, Chekir-Ghedira L, Ronot X (2012) Flavones inhibit the proliferation of human tumor cancer cell lines by inducing apoptosis. Drug Chem Toxicol 35:1–10CrossRefPubMed Kilani-Jaziri S, Frachet V, Bhouri W, Ghedira K, Chekir-Ghedira L, Ronot X (2012) Flavones inhibit the proliferation of human tumor cancer cell lines by inducing apoptosis. Drug Chem Toxicol 35:1–10CrossRefPubMed
45.
Zurück zum Zitat Su CC, Chen GW, Yeh CC, Yang MD, Hung CF, Chung JG (2003) Luteolin induces N-acetylation and DNA adduct of 2-aminofluorene accompanying N-acetyltransferase activity and gene expression in human bladder cancer T24 cell line. Anticancer Res 23:355–362PubMed Su CC, Chen GW, Yeh CC, Yang MD, Hung CF, Chung JG (2003) Luteolin induces N-acetylation and DNA adduct of 2-aminofluorene accompanying N-acetyltransferase activity and gene expression in human bladder cancer T24 cell line. Anticancer Res 23:355–362PubMed
46.
Zurück zum Zitat Cherng JM, Shieh DE, Chiang W, Chang MY, Chiang LC (2007) Chemopreventive effects of minor dietary constituents in common foods on human cancer cells. Biosci Biotechnol Biochem 71:1500–1504CrossRefPubMed Cherng JM, Shieh DE, Chiang W, Chang MY, Chiang LC (2007) Chemopreventive effects of minor dietary constituents in common foods on human cancer cells. Biosci Biotechnol Biochem 71:1500–1504CrossRefPubMed
47.
Zurück zum Zitat Shi MD, Shiao CK, Lee YC, Shih YW (2015) Apigenin, a dietary flavonoid, inhibits proliferation of human bladder cancer T-24 cells via blocking cell cycle progression and inducing apoptosis. Cancer Cell Int 15:33CrossRefPubMedPubMedCentral Shi MD, Shiao CK, Lee YC, Shih YW (2015) Apigenin, a dietary flavonoid, inhibits proliferation of human bladder cancer T-24 cells via blocking cell cycle progression and inducing apoptosis. Cancer Cell Int 15:33CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Liu Q, Chen X, Yang G, Min X, Deng M (2011) Apigenin inhibits cell migration through MAPK pathways in human bladder smooth muscle cells. Biocell 35:71–79PubMed Liu Q, Chen X, Yang G, Min X, Deng M (2011) Apigenin inhibits cell migration through MAPK pathways in human bladder smooth muscle cells. Biocell 35:71–79PubMed
49.
Zurück zum Zitat Zhu Y, Mao Y, Chen H, Lin Y, Hu Z, Wu J, Xu X, Xu X, Qin J, Xie L (2013) Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells. Cancer Cell Int 13:54CrossRefPubMedPubMedCentral Zhu Y, Mao Y, Chen H, Lin Y, Hu Z, Wu J, Xu X, Xu X, Qin J, Xie L (2013) Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells. Cancer Cell Int 13:54CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Xu C, Zeng XT, Liu TZ, Zhang C, Yang ZH, Li S, Chen XY (2015) Fruits and vegetables intake and risk of bladder cancer: a PRISMA-compliant systematic review and dose-response meta-analysis of prospective cohort studies. Medicine 94:e759CrossRefPubMedPubMedCentral Xu C, Zeng XT, Liu TZ, Zhang C, Yang ZH, Li S, Chen XY (2015) Fruits and vegetables intake and risk of bladder cancer: a PRISMA-compliant systematic review and dose-response meta-analysis of prospective cohort studies. Medicine 94:e759CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Park SY, Ollberding NJ, Woolcott CG, Wilkens LR, Henderson BE, Kolonel LN (2013) Fruit and vegetable intakes are associated with lower risk of bladder cancer among women in the Multiethnic Cohort Study. J Nutr 143:1283–1292CrossRefPubMedPubMedCentral Park SY, Ollberding NJ, Woolcott CG, Wilkens LR, Henderson BE, Kolonel LN (2013) Fruit and vegetable intakes are associated with lower risk of bladder cancer among women in the Multiethnic Cohort Study. J Nutr 143:1283–1292CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Al-Zalabani AH, Stewart KF, Wesselius A, Schols AM, Zeegers MP (2016) Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol 31:811–851CrossRefPubMedPubMedCentral Al-Zalabani AH, Stewart KF, Wesselius A, Schols AM, Zeegers MP (2016) Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol 31:811–851CrossRefPubMedPubMedCentral
53.
Zurück zum Zitat Dugue PA, Hodge AM, Brinkman MT, Bassett JK, Shivappa N, Hebert JR, Hopper JL, English DR, Milne RL, Giles GG (2016) Association between selected dietary scores and the risk of urothelial cell carcinoma: a prospective cohort study. Int J Cancer 139:1251–1260CrossRefPubMedPubMedCentral Dugue PA, Hodge AM, Brinkman MT, Bassett JK, Shivappa N, Hebert JR, Hopper JL, English DR, Milne RL, Giles GG (2016) Association between selected dietary scores and the risk of urothelial cell carcinoma: a prospective cohort study. Int J Cancer 139:1251–1260CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat De Stefani E, Boffetta P, Ronco AL, Deneo-Pellegrini H, Acosta G, Mendilaharsu M (2008) Dietary patterns and risk of bladder cancer: a factor analysis in Uruguay. Cancer Causes Control 19:1243–1249CrossRefPubMed De Stefani E, Boffetta P, Ronco AL, Deneo-Pellegrini H, Acosta G, Mendilaharsu M (2008) Dietary patterns and risk of bladder cancer: a factor analysis in Uruguay. Cancer Causes Control 19:1243–1249CrossRefPubMed
55.
Zurück zum Zitat Finglas PM, Berry R, Astley S (2014) Assessing and improving the quality of food composition databases for nutrition and health applications in Europe: the contribution of EuroFIR. Adv Nutr 5:608S–614SCrossRefPubMedPubMedCentral Finglas PM, Berry R, Astley S (2014) Assessing and improving the quality of food composition databases for nutrition and health applications in Europe: the contribution of EuroFIR. Adv Nutr 5:608S–614SCrossRefPubMedPubMedCentral
Metadaten
Titel
Flavonoids and bladder cancer risk
verfasst von
Marta Rossi
Panagiota Strikoudi
Maria-Eleni Spei
Maria Parpinel
Diego Serraino
Maurizio Montella
Massimo Libra
Carlo La Vecchia
Valentina Rosato
Publikationsdatum
22.03.2019
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 5/2019
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-019-01158-2

Weitere Artikel der Ausgabe 5/2019

Cancer Causes & Control 5/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.